There is no Morningtar’s Analysis data available.
Online Disruptive Technologies Inc is engaged in the business of development and commercialization of biotechnology platform. The firm's main product is Savicell platform with applications for cancer, autoimmune diseases, and infectious diseases. The firm has license to certain patented technology relating to the early detection of diseases by measuring metabolic activity in the immune system. The company operates in the United States and Israel.
Andover, MA, 01810-3572